Roberts, Glore & Co’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-6,570
| Closed | -$211K | – | 142 |
|
|
2017
Q1 | $211K | Sell |
6,570
-8,230
| -56% | -$264K | 0.15% | 135 |
|
|
2016
Q4 | $537K | Sell |
14,800
-2,925
| -17% | -$106K | 0.37% | 77 |
|
|
2016
Q3 | $816K | Sell |
17,725
-225
| -1% | -$10.4K | 0.59% | 53 |
|
|
2016
Q2 | $902K | Buy |
17,950
+20
| +0.1% | +$1.01K | 0.68% | 47 |
|
|
2016
Q1 | $959K | Sell |
17,930
-575
| -3% | -$30.8K | 0.73% | 43 |
|
|
2015
Q4 | $1.22M | Sell |
18,505
-300
| -2% | -$19.7K | 0.92% | 35 |
|
|
2015
Q3 | $1.06M | Sell |
18,805
-7,645
| -29% | -$432K | 0.83% | 38 |
|
|
2015
Q2 | $1.56M | Sell |
26,450
-625
| -2% | -$36.9K | 1.09% | 28 |
|
|
2015
Q1 | $1.69M | Sell |
27,075
-205
| -0.8% | -$12.8K | 1.16% | 26 |
|
|
2014
Q4 | $1.57M | Buy |
27,280
+215
| +0.8% | +$12.4K | 1.05% | 31 |
|
|
2014
Q3 | $1.46M | Sell |
27,065
-935
| -3% | -$50.3K | 1.01% | 31 |
|
|
2014
Q2 | $1.47M | Sell |
28,000
-750
| -3% | -$39.3K | 1% | 34 |
|
|
2014
Q1 | $1.52M | Sell |
28,750
-1,600
| -5% | -$84.5K | 1.05% | 30 |
|
|
2013
Q4 | $1.22M | Buy |
30,350
+1,775
| +6% | +$71.1K | 0.84% | 39 |
|
|
2013
Q3 | $1.08M | Sell |
28,575
-10,000
| -26% | -$378K | 0.8% | 40 |
|
|
2013
Q2 | $1.51M | Buy |
+38,575
| New | +$1.51M | 0.93% | 36 |
|